BioPharma APAC

Bio Insight

Thermo Fisher Scientific is responding by increasing capacity and diversifying into new geographies and innovative therapies

1) What strategic changes have you brought about within the business due to COVID-19? Essential to Thermo Fisher Scientific’s ability to support bi...

November 12, 2021 | Influencers

Final ‘foundation stones’ set for future of Australian regenerative medicine

Benchmarking the investment in the sector in Australia in 2019 and 2020, Australia’s Regenerative Medicine Investments Database reveals the ext...

November 01, 2021 | News

Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices

Therefore, owing to increasing patient pool, the demand for efficient imaging devices is projected to increase rapidly. Moreover, rising expenditure on car...

September 22, 2021 | Analysis

The Global Biopharma Resilience Index

As the world navigates the greatest public health crisis in recent memory, the biopharma industry has taken a leading role in fighting COVI...

September 17, 2021 | News

High Virus Count in the Lungs Drives Covid-19 Deaths

Led by researchers at NYU Grossman School of Medicine, the new study showed that people who died of COVID-19 had on average 10 times the amount of virus, o...

September 01, 2021 | Analysis

Rising Demand for Internet of Medical Things (IoMT) Market

The internet of medical things has significantly revolutionized the traditional paper-based to data management to real-time patient data and remote patient...

August 24, 2021 | News

Discovery Technologies: The Story of Remdesivir

Molecular Structure and Mode of Action Remdesivir, also known as GS-5734, is a carbolic ester with the molecular formula C27H35N6O8P. In vivo, remdes...

August 23, 2021 | Opinion

How Pfizer boosted security levels across its global manufacturing facilities

Secondly, OT networks are particularly vulnerable because they operate with many proprietary, and often legacy, devices that can be difficult to identify a...

August 18, 2021 | Opinion | By Guilad Regev, SVP Customer Care, Claroty

Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease

In a study presented at the Australasian Diabetes Congress today, researchers used PromarkerD, the world's first predictive diagnostic test for diabetic ki...

August 13, 2021 | News

Keeping An Eye And Ear On Patients’ Needs: Where AI Meets Supply Chain

“We want every patient to be able to get the medicines they need when they need them,” says Teresa Rodó, Merck Head of Global Healthcare...

August 11, 2021 | News

Varigard Tech, Proven to Prevent the Tactile Spread of SARS-CoV-2, B.1.617.2 - DELTA Variant

Varigard and Synergy Laboratories have announced the test results of an advanced hand sanitizing gel and surface disinfectant. The test results illustrated...

August 04, 2021 | News

Optical Imaging Facilitates Key Neurological Disease Research

Despite vast amounts of research into neurological diseases, most cannot be cured and only some have therapeutics available. These treatments either slow d...

July 29, 2021 | News

Oncology Drugs to Watch 2021

In this oncology edition of our Drugs to WatchTM series, Clarivate experts explore treatment breakthroughs highlighted at the ASCO Annual Meeting...

July 16, 2021 | Analysis

Staying flexible in biomanufacturing with optionality

The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you bet...

July 15, 2021 | Opinion | By Firman Ghouze, Cytiva, and Uriel Kusiatin, Provista Diagnostics Inc.

Stay Connected